Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Radial Extracorporeal Shockwave Therapy (rESWT) is not superior to minimal-dose rESWT for patients with chronic noninsertional achilles tendinopathy: a double-anonymized randomized controlled trial
Wheeler PC, Tattersall C, Calver R
Foot & Ankle International 2025 Jun;46(6):633-643
clinical trial
This trial has not yet been rated.

BACKGROUND: Outcomes following radial extracorporeal shockwave therapy (rESWT) in patients with chronic noninsertional Achilles tendinopathy are investigated. METHODS: Patients with chronic noninsertional Achilles tendinopathy were recruited from a single National Health Services clinic, randomized equally to either therapeutic or minimal-dose (presumed sham) rESWT (3 sessions at weekly intervals). Both groups had an identical structured home rehabilitation program of progressive loading, balance, and stretching exercises. RESULTS: Fifty-seven patients were recruited; mean age 49.7 +/- 7.2 years, 60% female, symptom duration: 22.2 +/- 19.5 months. No between-group differences were identified at the final or any interim time points. Clinically and statistically significant within-group improvements were identified in pain/local function patient-reported outcome measures for both groups, with average pain improving by 34% at 6 months. No consistent benefits were seen in global function, activity levels, or mood. CONCLUSION: Recommended-dose rESWT is not superior to minimal-dose rESWT and may be ineffective for patients with chronic noninsertional Achilles tendinopathy.

Full text (sometimes free) may be available at these link(s):      help